Chinese Journal of Pharmaceuticals
|
2022, 53(12): 1803-1809
• Pharmaceutical Management & Information •
Overview of Rationale and Criteria for Combining Neoplasms for Evaluation of Preclinical Rodent Carcinogenicity Studies
Full
Zhuang QIAN, Yaqun ZHANG, Yanchuan LI, Xiaojun CHEN, Jianjun LYU
*
Affiliations
- InnoStar Bio-tech Nantong Co., Ltd., Nantong 226133
Published: 2022-12-10
doi: 10.16522/j.cnki.cjph.2022.12.018
Outline
钱庄, 张亚群, 李言川, 陈晓俊, 吕建军.
药物临床前啮齿动物致癌试验肿瘤合并的基本原则和标准概述.
中国医药工业杂志,
2022
, 53
(12)
: 1803
-1809
.
DOI: 10.16522/j.cnki.cjph.2022.12.018
Zhuang QIAN, Yaqun ZHANG, Yanchuan LI, Xiaojun CHEN, Jianjun LYU.
Overview of Rationale and Criteria for Combining Neoplasms for Evaluation of Preclinical Rodent Carcinogenicity Studies[J].
Chinese Journal of Pharmaceuticals,
2022
, 53
(12)
: 1803
-1809
.
DOI: 10.16522/j.cnki.cjph.2022.12.018
Year 2022 volume 53 Issue 12
75
14
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2022.12.018
- Receive Date:2022-05-26
- Online Date:2026-11-12
- Published:2022-12-10